I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
It is used as a pharmaceutical intermediate.
Morihiro Mitsuya.; Kensuke Kobayashi.; Kumiko Kawakami.; Atsushi Satoh.; Yoshio Ogino.; Taro Kakikawa.; Norikazu Ohtake.; Toshifumi Kimura.; Hiroyasu Hirose.; Akio Sato.; Tomosige Numazawa.;Takuro Hasegawa.; Kazuhito Noguchi.; Toshiaki Mase. A Potent, Long-Acting, Orally Active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide:? A Novel Muscarinic M3 Receptor Antagonist with High Selectivity for M3 over M2 Receptors. J. Med. Chem. 2000, 43 (26),5017-5029.
Evan G. Robertson.; Matthew R. Hockridge.; Peter D. Jelfsa.; John P. Simons. IR-UV ion-depletion and fluorescence spectroscopy of2-phenylacetamide clusters: hydration of a primary amide. Phys. Chem. Chem. Phys. 2001, 3 (5),786-795.
Hazard Statements: H302-H319
Harmful if swallowed. Causes serious eye irritation.
Precautionary Statements: P264b-P270-P280i-P301+P312-P305+P351+P338-P330-P501c
Wash face, hands and any exposed skin thoroughly after handling Do not eat, drink or smoke when using this product. Wear eye/face protection. IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Rinse mouth. Dispose of contents/ container to an approved waste disposal plant